CJC-1295 DAC (5mg)

CJC-1295 with DAC (Drug Affinity Complex) is a synthetic growth hormone-releasing hormone (GHRH) analogue peptide designed for long-term activity within experimental research settings. It is widely studied within molecular and endocrine research due to its interaction with pathways involved in growth hormone signaling and regulatory processes.

The addition of the DAC (Drug Affinity Complex) allows CJC-1295 to bind to plasma proteins, significantly extending its half-life compared to non-DAC variants. Because of this, it is often used as a long-acting research peptide for studies of long-term pathway activation and signal modulation.

History of CJC-1295 DAC

CJC-1295 was developed within research into modified GHRH peptides that can provide prolonged biological activity. The addition of the DAC component created a compound with a longer circulation time, allowing for more stable interaction with growth hormone-regulating pathways.

Early studies focused on the dynamics of growth hormone pulses and signal duration. Later studies expanded to include endocrine signaling, metabolic regulation, and consistency of biological pathways.

Today, CJC-1295 DAC remains an important research peptide in studies of long-term signaling mechanisms.

CJC-1295 DAC Structure and Molecular Data

Peptide Name: CJC-1295 with DAC
Peptide Type: GHRH Analog
Molecular Formula: C152H252N44O42
Molecular Weight: ~3367.9 g/mol

CJC-1295 is a modified peptide derived from growth hormone-releasing hormone and is designed for increased stability and prolonged activity. The DAC component allows binding to albumin, which allows for longer circulation and long-term interaction with biological pathways.

CJC-1295 DAC Research Findings

CJC-1295 DAC has been extensively investigated in endocrine and molecular research models, with a focus on hormonal signaling and regulatory systems.

Research shows activity related to:

• Modulation of growth hormone signaling pathways
• Long-term receptor activation and signaling dynamics
• Regulation of endocrine pathways
• Consistency and duration of molecular signaling

Major Research Areas of CJC-1295 DAC

Endocrine Research
Focus on growth hormone-related signaling and pathway dynamics.

Molecular research
Study of receptor binding, signal duration and pathway modulation.

Metabolic Research
Research on interactions between hormonal signaling and metabolic processes.

Systemic Research
Analysis of long-term signaling within complex biological systems.

Scientific Relevance of CJC-1295 DAC

CJC-1295 with DAC is considered a long-acting investigational peptide specifically used to study long-term activation of growth hormone-related pathways.

The extended half-life allows researchers to analyze continuous signaling patterns, receptor interactions, and stability of pathways over time. This makes it particularly valuable for experimental models where long-term activity is required.

Due to its stability and design structure, CJC-1295 DAC remains an important compound in peptide research, molecular biology and endocrine studies.

References

Teichman SL. et al. (2006). Prolonged stimulation of growth hormone and IGF-1 levels with CJC-1295.

Mud UI. et al. (2011). Effects of long-acting GHRH analogs on endocrine signaling.

Veldhuis JD. et al. (2009). Regulation of growth hormone secretion dynamics.